The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancer

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2191-1991
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
The validation of published utility mapping algorithms: an example of EORTC QLQ-C30 and EQ-5D in non-small cell lung cancer ; volume:10 ; number:1 ; day:21 ; month:4 ; year:2020 ; pages:1-10 ; date:12.2020
Health economics review ; 10, Heft 1 (21.4.2020), 1-10, 12.2020

Classification
Medizin, Gesundheit

Creator
Gregory, Joanne
Dyer, Matthew
Hoyle, Christopher
Mann, Helen
Hatswell, Anthony J.
Contributor
SpringerLink (Online service)

DOI
10.1186/s13561-020-00269-w
URN
urn:nbn:de:101:1-2020070300282351205070
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:47 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Gregory, Joanne
  • Dyer, Matthew
  • Hoyle, Christopher
  • Mann, Helen
  • Hatswell, Anthony J.
  • SpringerLink (Online service)

Other Objects (12)

Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma

Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma

Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients

Mapping EORTC QLQ-C30 onto EQ-5D for the assessment of cancer patients

Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

Correction to: Mapping the EORTC QLQ-C30 to EQ-5D-3L in patients with breast cancer

Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer

Mapping EORTC QLQ-C30 and FACT-G onto EQ-5D-5L index for patients with cancer

Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer

Estimating the minimally important difference for the EQ-5D-5L and EORTC QLQ-C30 in cancer

Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients

Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients

Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13

Interpreting Within-Patient Changes on the EORTC QLQ-C30 and EORTC QLQ-LC13

Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after

Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after

Correction: Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after

Correction: Reference values of EORTC QLQ-C30, EORTC QLQ-BR23, and EQ-5D-5L for women with non-metastatic breast cancer at diagnosis and 2 years after

Assessing measurement invariance in the EORTC QLQ-C30

Assessing measurement invariance in the EORTC QLQ-C30

Psychometric properties of the EORTC QLQ-C30 in Uganda

Psychometric properties of the EORTC QLQ-C30 in Uganda

Related objects